Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer.

Gui C, Chintalapati N, Hales RK, Voong KR, Sair HI, Grimm J, Duhon M, Kleinberg LR, Vannorsdall TD, Redmond KJ.

J Neurooncol. 2019 Sep;144(2):351-358. doi: 10.1007/s11060-019-03235-7. Epub 2019 Jul 13.

PMID:
31302830
2.

Applying Non-Homogeneous Dose Optimization to Improve Conventionally Fractionated Radiation Plan Quality in Patients with Non-Small Cell Lung Cancer.

Hazell SZ, Hales RK, Hrinivich WT, Ford K, Kang-Hsin Wang K, McNutt TR, Han P, Anderson LJ, Ferro AC, Moore J, Voong KR.

Pract Radiat Oncol. 2019 Jun 25. pii: S1879-8500(19)30181-X. doi: 10.1016/j.prro.2019.06.010. [Epub ahead of print]

PMID:
31252089
3.

Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer.

Voong KR, Hazell SZ, Fu W, Hu C, Lin CT, Ding K, Suresh K, Hayman J, Hales RK, Alfaifi S, Marrone KA, Levy B, Hann CL, Ettinger DS, Feliciano JL, Peterson V, Kelly RJ, Brahmer JR, Forde PM, Naidoo J.

Clin Lung Cancer. 2019 Jul;20(4):e470-e479. doi: 10.1016/j.cllc.2019.02.018. Epub 2019 Mar 28.

PMID:
31031204
4.

Thoracic Oncology Multidisciplinary Clinic Reduces Unnecessary Health Care Expenditure Used in the Workup of Patients With Non-small-cell Lung Cancer.

Voong KR, Liang OS, Dugan P, Torto D, Padula WV, Senter JP, Lang M, Hooker CM, Feliciano J, Broderick S, Yarmus L, Khanna K, Narang A, Hales RK.

Clin Lung Cancer. 2019 Jul;20(4):e430-e441. doi: 10.1016/j.cllc.2019.02.010. Epub 2019 Mar 12.

PMID:
30956040
5.

Soft-Tissue Metastases From Esophageal Cancer.

El Abiad JM, Hales RK, Levin AS, Morris CD.

J Gastrointest Surg. 2019 Sep;23(9):1721-1728. doi: 10.1007/s11605-019-04160-w. Epub 2019 Feb 26.

PMID:
30809784
6.

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.

Suresh K, Psoter KJ, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, Hales RK, D'Alessio F, Danoff SK, Naidoo J.

J Thorac Oncol. 2019 Mar;14(3):494-502. doi: 10.1016/j.jtho.2018.11.016. Epub 2018 Nov 30.

PMID:
30503891
7.

Hemifacial Hyperhidrosis in a Patient With an Apical Non-Small Cell Lung Cancer.

Sloan L, Romo CG, Hales RK.

JAMA Oncol. 2019 Mar 1;5(3):422-423. doi: 10.1001/jamaoncol.2018.4597. No abstract available.

PMID:
30452491
8.

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.

Suresh K, Voong KR, Shankar B, Forde PM, Ettinger DS, Marrone KA, Kelly RJ, Hann CL, Levy B, Feliciano JL, Brahmer JR, Feller-Kopman D, Lerner AD, Lee H, Yarmus L, D'Alessio F, Hales RK, Lin CT, Psoter KJ, Danoff SK, Naidoo J.

J Thorac Oncol. 2018 Dec;13(12):1930-1939. doi: 10.1016/j.jtho.2018.08.2035. Epub 2018 Sep 26.

PMID:
30267842
9.

Underutilization of Combined-Modality Therapy in Limited-Stage Small Cell Lung Cancer.

Alcorn SR, Miller DB, Hales RK.

JAMA Oncol. 2018 Oct 1;4(10):1435-1436. doi: 10.1001/jamaoncol.2018.3261. No abstract available.

PMID:
30073331
10.

Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy.

Rettig EM, Fakhry C, Hales RK, Kisuule F, Quon H, Kiess AP, Yin LX, Zhang Y, Blackford AL, Drummond MB, Gourin CG, Koch WM, Eisele DW, D'Souza G.

Head Neck. 2018 Jul;40(7):1534-1547. doi: 10.1002/hed.25148. Epub 2018 Mar 15.

11.

A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation.

Ma TM, Grimm J, McIntyre R, Anderson-Keightly H, Kleinberg LR, Hales RK, Moore J, Vannorsdall T, Redmond KJ.

Radiother Oncol. 2017 Nov;125(2):234-240. doi: 10.1016/j.radonc.2017.09.035. Epub 2017 Nov 8.

PMID:
29128167
12.

In Reply to Belderbos et al.

Redmond KJ, Hales RK, Anderson-Keightly H, Zhou XC, Vannorsdall T.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):239-240. doi: 10.1016/j.ijrobp.2017.05.011. Epub 2017 Aug 7. No abstract available.

PMID:
28816153
13.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive-Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937.

Gore EM, Hu C, Sun AY, Grimm DF, Ramalingam SS, Dunlap NE, Higgins KA, Werner-Wasik M, Allen AM, Iyengar P, Videtic GMM, Hales RK, McGarry RC, Urbanic JJ, Pu AT, Johnstone CA, Stieber VW, Paulus R, Bradley JD.

J Thorac Oncol. 2017 Oct;12(10):1561-1570. doi: 10.1016/j.jtho.2017.06.015. Epub 2017 Jun 23.

14.

Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.

Redmond KJ, Hales RK, Anderson-Keightly H, Zhou XC, Kummerlowe M, Sair HI, Duhon M, Kleinberg L, Rosner GL, Vannorsdall T.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):603-611. doi: 10.1016/j.ijrobp.2017.03.009. Epub 2017 Mar 14.

PMID:
28581401
15.

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.

Verma V, Simone CB 2nd, Allen PK, Gajjar SR, Shah C, Zhen W, Harkenrider MM, Hallemeier CL, Jabbour SK, Matthiesen CL, Braunstein SE, Lee P, Dilling TJ, Allen BG, Nichols EM, Attia A, Zeng J, Biswas T, Paximadis P, Wang F, Walker JM, Stahl JM, Daly ME, Decker RH, Hales RK, Willers H, Videtic GM, Mehta MP, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):362-371. doi: 10.1016/j.ijrobp.2016.10.041. Epub 2016 Nov 2.

PMID:
28011047
16.

Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution.

Ellsworth SG, Alcorn SR, Hales RK, McNutt TR, DeWeese TL, Smith TJ.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1100-1105. doi: 10.1016/j.ijrobp.2014.04.028. Epub 2014 Jul 8.

17.

The twist box domain is required for Twist1-induced prostate cancer metastasis.

Gajula RP, Chettiar ST, Williams RD, Thiyagarajan S, Kato Y, Aziz K, Wang R, Gandhi N, Wild AT, Vesuna F, Ma J, Salih T, Cades J, Fertig E, Biswal S, Burns TF, Chung CH, Rudin CM, Herman JM, Hales RK, Raman V, An SS, Tran PT.

Mol Cancer Res. 2013 Nov;11(11):1387-400. doi: 10.1158/1541-7786.MCR-13-0218-T. Epub 2013 Aug 27.

18.

Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.

Alcorn S, Walker AJ, Gandhi N, Narang A, Wild AT, Hales RK, Herman JM, Song DY, Deweese TL, Antonarakis ES, Tran PT.

Int J Mol Sci. 2013 Jul 16;14(7):14800-32. doi: 10.3390/ijms140714800. Review.

19.

Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.

Wild AT, Gandhi N, Chettiar ST, Aziz K, Gajula RP, Williams RD, Kumar R, Taparra K, Zeng J, Cades JA, Velarde E, Menon S, Geschwind JF, Cosgrove D, Pawlik TM, Maitra A, Wong J, Hales RK, Torbenson MS, Herman JM, Tran PT.

PLoS One. 2013 Jun 6;8(6):e65726. doi: 10.1371/journal.pone.0065726. Print 2013.

20.

Novel Hsp90 inhibitor NVP-AUY922 radiosensitizes prostate cancer cells.

Gandhi N, Wild AT, Chettiar ST, Aziz K, Kato Y, Gajula RP, Williams RD, Cades JA, Annadanam A, Song D, Zhang Y, Hales RK, Herman JM, Armour E, DeWeese TL, Schaeffer EM, Tran PT.

Cancer Biol Ther. 2013 Apr;14(4):347-56. doi: 10.4161/cbt.23626. Epub 2013 Jan 28.

21.

Hedgehog pathway inhibition radiosensitizes non-small cell lung cancers.

Zeng J, Aziz K, Chettiar ST, Aftab BT, Armour M, Gajula R, Gandhi N, Salih T, Herman JM, Wong J, Rudin CM, Tran PT, Hales RK.

Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):143-9. doi: 10.1016/j.ijrobp.2012.10.014. Epub 2012 Nov 20.

22.

Tissue biomarkers for prostate cancer radiation therapy.

Tran PT, Hales RK, Zeng J, Aziz K, Salih T, Gajula RP, Chettiar S, Gandhi N, Wild AT, Kumar R, Herman JM, Song DY, DeWeese TL.

Curr Mol Med. 2012 Jul 1;12(6):772-87. Review.

23.

Nelfinavir induces radiation sensitization in pituitary adenoma cells.

Zeng J, See AP, Aziz K, Thiyagarajan S, Salih T, Gajula RP, Armour M, Phallen J, Terezakis S, Kleinberg L, Redmond K, Hales RK, Salvatori R, Quinones-Hinojosa A, Tran PT, Lim M.

Cancer Biol Ther. 2011 Oct 1;12(7):657-63. Epub 2011 Oct 1.

24.

Assessing oncologic benefit in clinical trials of immunotherapy agents.

Hales RK, Banchereau J, Ribas A, Tarhini AA, Weber JS, Fox BA, Drake CG.

Ann Oncol. 2010 Oct;21(10):1944-51. doi: 10.1093/annonc/mdq048. Epub 2010 Mar 17. Review.

PMID:
20237004
25.

Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis.

Hales RK, Shokek O, Burger PC, Paynter NP, Chaichana KL, Quiñones-Hinojosa A, Jallo GI, Cohen KJ, Song DY, Carson BS, Wharam MD.

J Neurooncol. 2010 Aug;99(1):65-71. doi: 10.1007/s11060-009-0102-3. Epub 2009 Dec 31.

PMID:
20043190

Supplemental Content

Loading ...
Support Center